Artisan Partners Limited Partnership Blueprint Medicines Corp Transaction History

Artisan Partners Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$82.78 - $101.0 $27.1 Million - $33.1 Million	-327,890 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$90.71 - $108.28 $1.09 Million - $1.3 Million	-12,014 Reduced 3.53%	327,890 $31.9 Million
Q4 2020 Feb 10, 2021	SELL	$92.08 - $124.48 $1.66 Million - $2.24 Million	-18,024 Reduced 5.04%	339,904 $38.1 Million
Q3 2020 Nov 12, 2020	BUY	$66.45 - $92.7 $10.2 Million - $14.2 Million	152,971 Added 74.64%	357,928 $33.2 Million
Q2 2020 Aug 12, 2020	BUY	$57.09 - $79.27 $11.7 Million - $16.2 Million	204,957 New	204,957 $16 Million

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.